
International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
AIMAR-2025
Conferences Published ↓
ICCE (2025)
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 4
July-August 2025
Indexing Partners



















Formulation and Evaluation of Immediate Release Dasatinib Film Coated Tablet
Author(s) | Ms. chanukya senapathi, Ms. SwarupaRani vemuru, Ms. Dharani Lakshmi Sadam, Mr. Vijay Boddu, Mr. Venu Gopal Chennupalli |
---|---|
Country | India |
Abstract | ABSTRACT: This study focuses on the Formulation and Evaluation of Immediate Release Dasatinib Film Coated Tablet. Oral drug delivery is the most widely utilized route of administration among all the routes that have been explored for systemic delivery of drugs via pharmaceutical products of different dosage forms. Various formulations were prepared by direct compression technique using super disintegrants (cross carmellose sodium, sodium starch glycolate etc.) The main objective is to achieve immediate drug release profile for the developed formulation. Optimized formulation was selected and its in-vitro release profile should be comparable with the reference product (Sprycel). The Stability studies were performed on the optimized formulation. Formulation of tablets by direct compression method. Evaluation of formulated tablets by performing various tests. Dasatinib, Microcrystalline cellulose, Chemicals are used. The formulation and evaluation of immediate release Dasatinib film coated tablets for the treatment of Lymphoblast Phase chronic myeloid leukemia. this preformulating studies performed for the drug and excipients as per the standard procedure. Immediate release drug delivery is a conventional type of drug delivery. The optimized formulation was subjected to stability studies and it was found to be stable. |
Keywords | Key word: Dasatinib, cross Carmel lose sodium, sodium starch glycolate , crospovidone. |
Field | Medical / Pharmacy |
Published In | Volume 7, Issue 3, May-June 2025 |
Published On | 2025-06-28 |
DOI | https://doi.org/10.36948/ijfmr.2025.v07i03.49054 |
Short DOI | https://doi.org/g9rsm2 |
Share this

E-ISSN 2582-2160

CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
